Search

everythinglearnresearchcommunity

for

Search:↓

Topical patidegib gel effectively treats basal cell carcinoma in Gorlin syndrome patients without causing the side effects seen with oral treatments.

Androgens reduce macrophage receptor expression, affecting immune response, while antiandrogens counteract this effect.

Activating Tgr5 may help treat hair loss and bone loss.

5-ARI therapy may help prevent prostate cancer progression.

Dihydrotestosterone changes some hormone-related gene expressions in rat pituitary glands but doesn't affect the estrous cycle.

Semaglutide is an effective weekly treatment for obesity, promoting weight loss and improving health, despite some side effects.

Piperonylic acid may help hair growth and treat hair loss.

Blocking TGFβ can help treat fibrotic skin conditions by promoting fat cell formation.

Ginsenoside Rg3 from Panax ginseng can lighten skin by reducing melanin production.

Ginsenoside Rb1 slows down aging in mice by affecting cell growth, cell death, and metabolism.

5-alpha reductase inhibitors and spironolactone don't increase gynecological tumor risk, glucagon-like-peptide-1 receptor agonists may increase alopecia risk, sanitary pads can cause dermatitis, early hidradenitis suppurativa intervention is crucial for Hispanic patients, community education boosts skin cancer awareness, metformin may improve skin cancer survival, LNG-IUDs can increase acne risk, machine learning accurately detects basal cell carcinoma, JAK-inhibitors may raise miscarriage risk, inclusive skincare ads affect those with darker skin, and CCCA in Black women might involve autoimmunity.

Upadacitinib may effectively treat resistant lichen planopilaris.

Thyroid receptor β can help develop new drugs to treat hair loss.

Treatment with a hormone agonist can reduce excess male hormones in postmenopausal women without surgery.

Panitumumab treatment can cause unusual hair growth in some colorectal cancer patients.

The S1PR 1&4 modulator may effectively treat alopecia areata by reducing hair loss and immune cell activity.

Enobosarm significantly increased muscle mass and improved physical function in elderly men and postmenopausal women without serious side effects.

Starting 5-alpha reductase inhibitors does not significantly increase the risk of rhabdomyolysis in older men, but is linked to a higher risk of muscle conditions.

5α-reductase inhibitors may help with prostate cancer but could increase the risk of severe tumors, so careful use is advised.

Blocking certain brain processes reduces mating behavior in female rats.

JAK inhibitors help treat some diseases but may increase risks of blood clots and cancer in certain patients.

Manipulating 5α-reductase type 2 can affect liver fat production and glucocorticoid effects.

Overexpressing SSAT enzyme reduces prostate tumor growth in mice.

Increased energy use in Pik3r1-related insulin resistance isn't due to Ucp1 thermogenesis.

Treprostinil, a drug, can delay wound healing in healthy cells but doesn't affect diabetic foot ulcer cells, suggesting further research could help understand its role in treating these ulcers.

Exemestane may protect bones by stimulating osteoblast growth through androgen-related pathways.

Ripretinib is effective and safe for treating advanced GIST in Chinese patients, particularly for non-gastric GISTs.

Non-coding RNA boosts retinoic acid production and signaling, aiding regeneration.

5 alpha reductase inhibitors can cause sexual, cognitive, and muscle side effects, and may slightly increase aggressive cancer risk.